U.S. commits $4 billion to international COVAX vaccine alliance
![White House image](/sites/default/files/styles/900x400/public/2020-02/banner-white-house-900x400.jpg?itok=Xl5rbh7h)
President Biden today told a group of G-7 leaders that the U.S. will support the COVAX alliance tasked with distributing COVID-19 vaccines to 92 low- and middle-income countries.
The program is co-administered by the World Health Organization and international vaccine alliance Gavi. The U.S.-contributed funds includes $2 billion appropriated by Congress in December, with an additional $2 billion through 2021 and 2022. The program’s goal is to vaccinate 20% of people living in the 92 target countries.
Related News Articles
Headline
The Centers for Disease Control and Prevention's COVID-19 data tracker shows an 18.1% test positivity rate for the week ending Aug. 10, the highest it has been…
Headline
The Centers for Disease Control and Prevention Aug. 13 issued an advisory alerting of an uptick of cases of parvovirus B19 across the U.S. Parvovirus B19 is a…
Blog
The RAND Corporation recently released the fifth iteration of its biannual hospital price report. The AHA has previously highlighted significant flaws with…
Headline
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
The Pfizer and Moderna COVID-19 vaccines can cause myocarditis, but do not appear to cause infertility, Guillain-Barré syndrome, Bell’s palsy, thrombosis with…
Headline
The Food and Drug Administration recently granted emergency use authorization for the first over-the-counter home antigen test to detect both flu and COVID-19…